Description
ERBITUX 100 AND 200MG VIALS (CHEMOTHERAPY)
First action · last action
2011-12-23 · 2011-12-23
Transactions
1
First transaction's obligation
$107,531
Base + all options value (sum of deltas)
$107,531
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5282B
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-12-23+$107,531= $107,531
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-12-23 | +$107,531 | $107,531 | ERBITUX 100 AND 200MG VIALS (CHEMOTHERAPY) |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI UFGKB2B71N12)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24926N0651 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $378,650 | FY2026 |
| 36C24926N0658 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $364,139 | FY2026 |
| 36C24526N0790 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $199,047 | FY2026 |
| 36C24526N0785 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $51,333 | FY2026 |
| 36C24526N0776 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $300,000 | FY2026 |
| 36C24526N0784 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $10,888 | FY2026 |
Other recipients under 6505 from 672-SAN JUAN (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24812F4297 | BAXTER HEALTHCARE CORPORATION | 672-SAN JUAN | $46,534 | FY2012 |
| VA24812F3323 | BAXTER HEALTHCARE CORPORATION | 672-SAN JUAN | $46,534 | FY2012 |
| VA24812F3324 | BAYER CORPORATION | 672-SAN JUAN | $61,131 | FY2012 |
| VA24812P0491 | MCKESSON PHARMACEUTICAL | 672-SAN JUAN | $6,671 | FY2012 |
| VA24812F0379 | BAXTER HEALTHCARE CORPORATION | 672-SAN JUAN | $48,174 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24812F0833_3600_V797P5282B_3600 · retrieved 2026-09-26.